Glucose Monitor Manufacturers Wary As DME Competitive Bidding Looms
This article was originally published in The Gray Sheet
Executive Summary
Blood glucose monitors and test strips are product areas that may fall under a competitive bidding model in upcoming Medicare reform legislation, according to device stakeholders
You may also be interested in...
House Medicare Bill Expands Competitive Bidding To DME Infusion Products
Device industry concerns that an expanded Medicare competitive bidding program would eventually include new, high-end technologies may be alleviated by language in the "Medicare Prescription Drug & Modernization Act" of 2003, which specifically excludes Class III devices
House Medicare Bill Expands Competitive Bidding To DME Infusion Products
Device industry concerns that an expanded Medicare competitive bidding program would eventually include new, high-end technologies may be alleviated by language in the "Medicare Prescription Drug & Modernization Act" of 2003, which specifically excludes Class III devices
Competitive Bidding For High-End Devices? Ways & Means Reiterates “No”
A competitive bidding model that would give physicians the discretionary ability to prescribe a particular product brand is being evaluated by the House Ways & Means Committee